Deciding on the best pharmacotherapy for advanced triple-negative breast cancer: expert guidance

Authors :: Carla Corvaja
Beatrice Taurelli Salimbeni
Eleonora Nicolò
Fabio Puglisi
Giuseppe Curigliano
Source :: Expert Opinion on Pharmacotherapy. 23:1765-1770
Publication Year :: 2022
Publisher :: Informa UK Limited, 2022.

Subjects :: Pharmacology
ADC
BRCA1/2
Receptor, ErbB-2
Humans
HER2-low breast cancer
Triple Negative Breast Neoplasms
Pharmacology (medical)
immunotherapy
General Medicine
TNBC
targeted therapies

Full Text Access

Tools